Update on Santhera, Idbenone in DMD and SIDEROS Trial

This webinar provided an update from Santhera Pharmaceuticals about the SIDEROS trial of idebenone in boys taking steroids.  Santhera also provided an update about their regulatory efforts to bring this treatment to boys with Duchenne in the US and Europe.

Click here to watch the recording of the webinar. You’ll be prompted to enter your name and email address to view the recording.

Related Posts

Share This Page

Make an Impact

You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.

Donate